Stock Events

Stock Events

Tonix Pharmaceuticals (TNXP) Q4 2024 Earnings

12NovConfirmed

Q3 2023

Q2 2024

Q3 2024

Q4 2024

-388

-259.16

-130.33

-1.49

Details

Expected EPS

-388

Actual EPS

-23

Surprise EPS

365

Surprise Percent

+94.07%

Description

Tonix Pharmaceuticals (TNXP) has reported earnings of -23 per share for Q4 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.